Cargando…

Body Composition, Metabolic Characteristics, and Insulin Resistance in Obese and Nonobese Women with Polycystic Ovary Syndrome

OBJECTIVES: The objective was to compare body composition, metabolic characteristics, and insulin resistance between obese (body mass index [BMI] ≥25 kg/m(2)) polycystic ovary syndrome (PCOS) and nonobese PCOS (BMI <25 kg/m(2)) women and their age- and BMI-matched controls. MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Satyaraddi, Anil, Cherian, Kripa Elizabeth, Kapoor, Nitin, Kunjummen, Aleyamma Thaiparambil, Kamath, Mohan S., Thomas, Nihal, Paul, Thomas V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594114/
https://www.ncbi.nlm.nih.gov/pubmed/31293320
http://dx.doi.org/10.4103/jhrs.JHRS_2_19
Descripción
Sumario:OBJECTIVES: The objective was to compare body composition, metabolic characteristics, and insulin resistance between obese (body mass index [BMI] ≥25 kg/m(2)) polycystic ovary syndrome (PCOS) and nonobese PCOS (BMI <25 kg/m(2)) women and their age- and BMI-matched controls. MATERIALS AND METHODS: A total of 81 PCOS women (Rotterdam criteria) (obese – 42; nonobese – 39) and 86 controls (obese – 42; nonobese –44) were recruited in this cross-sectional study. All women underwent a detailed assessment of clinical, anthropometric, and metabolic parameters, insulin resistance indices, and body composition measurements with visceral adipose tissue assessment (VAT) (dual-energy X-ray absorptiometry scan). RESULTS: Of PCOS women, 27% (80% – obese PCOS; 20% – nonobese PCOS) were diagnosed with metabolic syndrome (International Diabetes Federation criteria), 35% of PCOS women (46% – obese PCOS; 54% – nonobese PCOS) had impaired glucose tolerance, and 7% of PCOS women (2/3(rd) – obese PCOS; 1/3(rd) – nonobese PCOS) had diabetes mellitus. Insulin resistance was seen in about 80% in obese PCOS women and 20% in nonobese PCOS women based on various insulin resistance indices such as fasting insulin (≥12.2 μU/ml), Homeostasis Model Assessment-Insulin Resistance (≥2.5), and Quantitative Insulin Sensitivity Check Index (<0.33). Total body fat, estimated (Est.) VAT, and corrected Est. VAT (corrected for body weight) were significantly increased (P = 0.0001) in both obese and nonobese PCOS women when compared to those of their age- and BMI-matched controls. However, corrected Est. VAT (corrected for body weight) was not significantly different between obese and nonobese PCOS women. CONCLUSION: Both obese and nonobese PCOS women when compared with their age- and BMI-matched controls were metabolically worse and had more visceral adiposity. Nonobese PCOS poses similar risk as that of obese PCOS in having similar amount of VAT (corrected for body weight).